Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells

BACKGROUND AND AIM: As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the connection between...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Luping, Morine, Yuji, Yamada, Shinichiro, Saito, Yu, Ikemoto, Tetsuya, Tokuda, Kazunori, Takasu, Chie, Miyazaki, Katsuki, Shimada, Mitsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412368/
https://www.ncbi.nlm.nih.gov/pubmed/34473785
http://dx.doi.org/10.1371/journal.pone.0256755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412368/
https://www.ncbi.nlm.nih.gov/pubmed/34473785
http://dx.doi.org/10.1371/journal.pone.0256755

Ejemplares similares